Medazepam

DB13437

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 270.757
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

824 Data
Buprenorphine Medazepam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Medazepam.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Medazepam.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Medazepam.
Hydrocodone Medazepam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Medazepam.
Magnesium sulfate The therapeutic efficacy of Medazepam can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Medazepam may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Medazepam may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Medazepam.
Mirtazapine Medazepam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Medazepam.
Orphenadrine Medazepam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Medazepam may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Medazepam.
Pramipexole Medazepam may increase the sedative activities of Pramipexole.
Ropinirole Medazepam may increase the sedative activities of Ropinirole.
Rotigotine Medazepam may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Medazepam.
Suvorexant Medazepam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Medazepam.
Thalidomide Medazepam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Medazepam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Clozapine The risk or severity of adverse effects can be increased when Medazepam is combined with Clozapine.
Methadone Medazepam may increase the central nervous system depressant (CNS depressant) activities of Methadone.
Phenytoin The serum concentration of Phenytoin can be increased when it is combined with Medazepam.
Fosphenytoin The serum concentration of Fosphenytoin can be increased when it is combined with Medazepam.
Sodium oxybate Medazepam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Teduglutide The serum concentration of Medazepam can be increased when it is combined with Teduglutide.
Yohimbine The therapeutic efficacy of Medazepam can be increased when used in combination with Yohimbine.
Mefloquine The therapeutic efficacy of Medazepam can be decreased when used in combination with Mefloquine.
Mianserin The therapeutic efficacy of Medazepam can be decreased when used in combination with Mianserin.
Orlistat Orlistat can cause a decrease in the absorption of Medazepam resulting in a reduced serum concentration and potentially a decrease in efficacy.
Topotecan Medazepam may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.
Flumazenil Flumazenil may decrease the sedative activities of Medazepam.
Tetracosactide The risk or severity of liver damage can be increased when Tetracosactide is combined with Medazepam.
Ethanol Medazepam may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Azelastine Medazepam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Brimonidine Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Medazepam.
Zimelidine The risk or severity of adverse effects can be increased when Medazepam is combined with Zimelidine.
Dapoxetine The risk or severity of adverse effects can be increased when Medazepam is combined with Dapoxetine.
Seproxetine The risk or severity of adverse effects can be increased when Medazepam is combined with Seproxetine.
Fluvoxamine The risk or severity of adverse effects can be increased when Medazepam is combined with Fluvoxamine.
Citalopram The risk or severity of adverse effects can be increased when Medazepam is combined with Citalopram.
Duloxetine The risk or severity of adverse effects can be increased when Medazepam is combined with Duloxetine.
Trazodone The risk or severity of adverse effects can be increased when Medazepam is combined with Trazodone.
Paroxetine The risk or severity of adverse effects can be increased when Medazepam is combined with Paroxetine.
Sertraline The risk or severity of adverse effects can be increased when Medazepam is combined with Sertraline.
Sibutramine The risk or severity of adverse effects can be increased when Medazepam is combined with Sibutramine.
Nefazodone The risk or severity of adverse effects can be increased when Medazepam is combined with Nefazodone.
Escitalopram The risk or severity of adverse effects can be increased when Medazepam is combined with Escitalopram.
Milnacipran The risk or severity of adverse effects can be increased when Medazepam is combined with Milnacipran.
Desvenlafaxine The risk or severity of adverse effects can be increased when Medazepam is combined with Desvenlafaxine.
Levomilnacipran The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Medazepam.
Indalpine The risk or severity of adverse effects can be increased when Medazepam is combined with Indalpine.
Ritanserin The risk or severity of adverse effects can be increased when Medazepam is combined with Ritanserin.
Alaproclate The risk or severity of adverse effects can be increased when Medazepam is combined with Alaproclate.
Cyproheptadine The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Medazepam.
Propiomazine The risk or severity of CNS depression can be increased when Propiomazine is combined with Medazepam.
Cocaine The risk or severity of methemoglobinemia can be increased when Medazepam is combined with Cocaine.
Quinidine The therapeutic efficacy of Medazepam can be decreased when used in combination with Quinidine.
Olanzapine The risk or severity of CNS depression can be increased when Olanzapine is combined with Medazepam.
Zopiclone The risk or severity of adverse effects can be increased when Medazepam is combined with Zopiclone.
Caffeine The therapeutic efficacy of Medazepam can be decreased when used in combination with Caffeine.
Theophylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Theophylline.
Dyphylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Dyphylline.
Pentoxifylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Pentoxifylline.
Mercaptopurine The therapeutic efficacy of Medazepam can be decreased when used in combination with Mercaptopurine.
Aminophylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Aminophylline.
Oxtriphylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Oxtriphylline.
Theobromine The therapeutic efficacy of Medazepam can be decreased when used in combination with Theobromine.
Fenethylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Fenethylline.
8-azaguanine The therapeutic efficacy of Medazepam can be decreased when used in combination with 8-azaguanine.
7,9-Dimethylguanine The therapeutic efficacy of Medazepam can be decreased when used in combination with 7,9-Dimethylguanine.
Xanthine The therapeutic efficacy of Medazepam can be decreased when used in combination with Xanthine.
7-Deazaguanine The therapeutic efficacy of Medazepam can be decreased when used in combination with 7-Deazaguanine.
Guanine The therapeutic efficacy of Medazepam can be decreased when used in combination with Guanine.
9-Methylguanine The therapeutic efficacy of Medazepam can be decreased when used in combination with 9-Methylguanine.
Peldesine The therapeutic efficacy of Medazepam can be decreased when used in combination with Peldesine.
Hypoxanthine The therapeutic efficacy of Medazepam can be decreased when used in combination with Hypoxanthine.
9-Deazaguanine The therapeutic efficacy of Medazepam can be decreased when used in combination with 9-Deazaguanine.
Propentofylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Propentofylline.
Valomaciclovir The therapeutic efficacy of Medazepam can be decreased when used in combination with Valomaciclovir.
3-isobutyl-1-methyl-7H-xanthine The therapeutic efficacy of Medazepam can be decreased when used in combination with 3-isobutyl-1-methyl-7H-xanthine.
Uric acid The therapeutic efficacy of Medazepam can be decreased when used in combination with Uric acid.
Doxofylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Doxofylline.
6-O-benzylguanine The therapeutic efficacy of Medazepam can be decreased when used in combination with 6-O-benzylguanine.
Lisofylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Lisofylline.
Lobucavir The therapeutic efficacy of Medazepam can be decreased when used in combination with Lobucavir.
Cafedrine The therapeutic efficacy of Medazepam can be decreased when used in combination with Cafedrine.
Theodrenaline The therapeutic efficacy of Medazepam can be decreased when used in combination with Theodrenaline.
Bamifylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Bamifylline.
Proxyphylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Proxyphylline.
Acefylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Acefylline.
Etamiphylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Etamiphylline.
Pentifylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Pentifylline.
Bufylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Bufylline.
Bromotheophylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Bromotheophylline.
Furafylline The therapeutic efficacy of Medazepam can be decreased when used in combination with Furafylline.
8-chlorotheophylline The therapeutic efficacy of Medazepam can be decreased when used in combination with 8-chlorotheophylline.

Target Protein

GABA(A) Receptor GABRA1
GABA(A) Receptor Benzodiazepine Binding Site GABRA1

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul